Rectal Cancer Cookbook Update. A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux

Similar documents
Handling & Grossing of Colo-rectal Specimens for Tumours. for Medical Officers in Pathology

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

RECTAL CARCINOMA: A DISTANCE APPROACH. Stephanie Nougaret

IMAGING GUIDELINES - COLORECTAL CANCER

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Gastric Cancer Histopathology Reporting Proforma

11/21/13 CEA: 1.7 WNL

A916: rectum: adenocarcinoma

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

Early colorectal cancer Quality and rules for a good pathology report Histoprognostic factors

Carcinoma of the Renal Pelvis and Ureter Histopathology

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING

Collaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ]

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum

Carcinoma of the Urinary Bladder Histopathology

Staging of rectal cancer on MRI: What the surgeons want to know.

Definition of Synoptic Reporting

What Pathology can tell us in the approach of localized colorectal cancer

Oncology Review article High-Resolution MRI in Rectal Cancer

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Protocol for the Examination of Specimens from Patients with Primary Carcinoma of the Colon and Rectum

Overview. Collecting Cancer Data: Colon 11/5/2009. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda NAACCR WEBINAR SERIES

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Standards and datasets for reporting cancers. Dataset for histopathological reporting of colorectal cancer. December 2017

Colon and Rectum 5/1/14

CRC Surgery Educational Slide Deck. Dr. Andy Smith Sunnybrook Surgical Oncology Research Group Department of Surgery University of Toronto

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS

COLORECTAL CARCINOMA

A215- Urinary bladder cancer tissues

Imaging in gastric cancer

Catholic University of Louvain, St - Luc University Hospital Head and Neck Oncology Programme. Anatomopathology. Pathology 1 Sept.

Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas.

Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum

Role of MRI for Staging Rectal Cancer

COLORECTAL CANCER STAGING in 2010

Rectal Cancer: Classic Hits

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do?

COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Protocol for the Examination of Specimens from Patients with Primary Carcinomas of the Colon and Rectum

Pathohistological Assessment of the Circular Margin of Resection During Total Mesorectal Excision, Conducted on The Malignant Formations of the Rectum

L impatto dell imaging sulla definizione della strategia terapeutica

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Alison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

Formula One Study. Assessment criteria of pathological parameters. Ver.2. UK Japan Joint Study for Risk Factors of Lymph Node

A Comparative Study of Rectal and Colonic Carcinoma: Demographic, Pathologic and TNM Staging Analysis

[A RESEARCH COORDINATOR S GUIDE]

Ritu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL

ACRIN 6666 Therapeutic Surgery Form

References. GI Biopsies. What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Optimization of Surgical and Pathological Quality Performance in Radical Surgery for Colon and Rectal Cancer: Margins and Lymph Nodes

12/7/2011. The reporting of colorectal cancer pathology: recent advances. Colorectal cancer resection specimens

AJCC 7 th Edition Staging Disease Site Webinar Colorectum

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Colorectum. Overview. This webinar is sponsored by

3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

UICC TNM 8 th Edition Errata

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

Seventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

RECTAL CANCER CLINICAL CASE PRESENTATION

UICC TNM 8 th Edition Errata

Neoplasms of the Colon and of the Rectum

2014/2015 FCDS Educational Webcast Series

PROCARE FINAL FEEDBACK Definitions

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Peritoneal Involvement in Stage II Colon Cancer

Case presentation. Eran Zittan. MD Mount Sinai Hospital, Toronto, Canada. Emek Medical Center, Afula, Israel. March, 2016

Disclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose

AJCC Cancer Staging 8 th Edition

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

Pathology of Treated GI Neoplasia

COLORECTAL CANCER: PROGNOSTIC VALUES

Vulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva Malignant melanoma sho

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

TOPICS FOR DISCUSSION

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

Management of pt1 polyps. Maria Pellise

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Colon and Rectum (Sarcomas, lymphomas, and carcinoid tumors of the large intestine are not included)

Transcription:

Rectal Cancer Cookbook Update A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux

Prof Dr A Jouret-Mourin, Department of Pathology, UCL, St Luc, Brussels anne.mourin@uclouvain.be Prof Dr A Hoorens, Department of Pathology, VUB, Brussels Prof Dr P Demetter, Department of Pathology, ULB, Erasme, Brussels Prof Dr G De Hertogh, Department of Pathology, KUL, Leuven Prof Dr C Cuvelier, Department of Pathology, UZ,Gent Prof Dr C Sempoux, Department of Pathology, UCL,St Luc, Brussels

TME is the standard surgical treatment for rectal cancer The pathologist has a crucial role in this process assessment of the completeness and quality of the resection prognosis choice of additional treatment

TME macroscopic inspection TME resection specimens require Specific macroscopic handling Specific pathological work-up Therefore, the resection specimen should be delivered fresh,unfixed to the laboratory (within 2 or 3 hours) unopened and unpinned

TME macroscopic inspection It is mandatory to determine the exact topography of the tumour, with reference to the serosal surface, i.e. above, at or below the peritoneal fold of Douglas (*). * * * *

TME macroscopic inspection It is mandatory to photograph the external surface of the TME : anterior and posterior surface to document the quality of the surgical specimen The description of the quality of the mesorectal surface is limited to the rectum above the sphincters

TME macroscopic inspection The mesorectum is the visceral mesentery ( fatty connective tissue layer enveloped by a thin fascia) surrounding the rectum. The mesorectal surface should be assessed The quality of the mesorectum can be graded.

TME macroscopic inspection Grading of the quality of mesorectal excision Mesorectum Defects Coning CRM Complete (grade 3) Intact, smooth, no violation of the fat Not deeper than 5 mm None Smooth, regular Nearly complete (grade 2) Moderate bulk, irregular surface No visible muscularis propria Moderate Mildly irregular Incomplete (grade 1) Little bulk, substantial loss Down to muscularis propria Moderate or marked Severely irregular Quirke P, Histopathology 2007; Parfitt JR, J Clin Pathol 2007 The anterior aspect is the most susceptible because there is less mesorectal tissue!

TME macroscopic inspection Complete excision- grade 3 - DOUGLAS FOLD Anterior Posterior

TME macroscopic inspection Complete excision- grade 3 - Anterior : DOUGLAS FOLD Latero-posterior

TME macroscopic inspection Incomplete excision grade 1 -

TME macroscopic inspection After examination of the external surface, one should ink the mesorectum surface before opening of the specimen

TME macroscopic inspection The specimen is opened anteriorly longitudinally from its proximal end downwards without extension into the tumour!

TME handling the specimen The resection specimen should be pinned out on a corkboard to avoid shrinkage and left floating with the cork upwards in formalin fixative during 48 h to 72 hours ( long fixation time is required to make the tissue firmer and facilitates serial cross-sectional slicing). NB Tumour cell density may be insufficient in treated tumours to perform Kras or MSI analysis. For this reason, it is very important to make gastroenterologist aware that they should try to obtain sufficient material in pretreatment biopsies.

TME handling the specimen We can place gauze or paper tissue wick soaked in formalin within the lumen of the intact bowel segment to enhance fixation

TME handling the specimen The resection specimen should be sectioned in parallel cuts of 3 4 mm perpendicular to the length of the bowel allowing to assess the deepest point of invasion and to measure the distance to the nearest lateral surface to be reported in mm.

TME handling the specimen Both the specimen as a whole as well as the transverse slides should be examined for adequate evaluation of the quality of mesorectal excision. These parallels cuts must also be photographed. In addition, they document the extend of the disease

TME handling the specimen Complete mesorectum Incomplete mesorectum

TME handling the specimen The circumferential margin (CRM) is defined as the distance between the deepest point of extension of the tumour and the non peritonealised circumferential surface This CRM must be measured and reported in mm

To measure the CRM: No distinction should be made between various modes of involvement i.e. direct spread, involved lymph node, lymphatic or vascular spread. CRM if, N +

TME handling the specimen The lateral margin refers to tumours located above the peritoneal reflection (above the Douglas fold) and is defined as the distance between the deepest point of extension of the tumour and the non peritonealised posterior resection margin ( inked surface).

TME handling the specimen Number of blocks from the tumour: 3 to 5 at minimum. One block should at least include the transition from the surrounding normal mucosa to the tumour At least one other should include the deepest point of invasion to measure CRM. One block should include to prove microscopically incomplete mesorectum ( grade 1)

TME handling the specimen Proximal and distal section margins do not have to be embedded if the tumour is situated at a distance of more than 3 cm from these margins. If the tumour is close to a margin, it is useful to sample this margin and to demonstrate the relationship to the tumour by perpendicular sections.

TME handling the specimen Tissue blocks have to be taken to assess the circumferential (radial) or lateral margin Following radiotherapy, it is often impossible to distinguish therapy-induced fibrosis from tumour invasion. In this case, sufficient tissue blocks should be taken from all macroscopically suspected areas

TME handling the specimen Tissue slices can be embedded as large area ( macro block) or as conventional small blocks

TME handling the specimen All lymph nodes included in the resection specimen are considered to be regional. The regional lymph nodes of the rectum are : perirectal, sigmoid mesenteric, inferior, lateral sacral, presacral, internal iliac, sacral promontory (Gerota s), internal iliac, superior rectal (haemorrhoidal), middle rectal (haemorrhoidal), inferior rectal (haemorrhoidal).

TME handling the specimen As much as possible lymph nodes should be found and embedded. One microscopic section should be taken through each lymph node. However it may be difficult to find lymph nodes in rectum resection, in particular after preoperative radiochemotherapy. The number of lymph nodes retrieved depends mainly on the effort of the pathologist. There is insufficient scientific evidence to recommend microdissection techniques or fat clearance.

TME handling the specimen Associated lesions ( polyps, IBD ) also have to be sampled

TME - Pathology report The pathology report is standardized providing all important macroscopic and microscopic data The check list should be used PROCARE uses TNM 5th edition with some additional items

TME - Pathology report - macroscopic data Measurements of specimen(s) Tumour: Localisation in relationship to the peritoneal lining. the proximal, distal and circumferential or lateral section margins Maximal length of tumour Macroscopic appearance Perforation Peritoneal deposits Associated lesions

Pathology report microscopic data pt : Depth of invasion: T0 Tx Tis T1 T2 T3 No evidence of primary tumour Tumour cannot be assessed Intra-epithelial or intra-mucosal carcinoma Tumour invades but limited to submucosa Tumour invades but limited to muscularis propria Tumour invades through muscularis propria into subserosa ( for peritonealised tumour)

Pathology report microscopic data T3a mesorectal invasion < 1mm beyond muscularis propria T3b mesorectal invasion 1-4 mm beyond muscularis propria T3c mesorectal invasion 5-15 mm beyond muscularis propria T3d mesorectal invasion > 15 mm beyond muscularis propria T4a Tumour perforates visceral peritoneum (is not circumferential resection margin positive!) T4b Tumour invades adjacent organs

Pathology report microscopic data pn : Lymph node involvement: Number of positive lymph nodes/ Number of lymph nodes analysed insufficient scientific evidence to mandate semi-serial sectioning or to perform immunohistochemical stains. N0 No regional lymph node metastasis Nx Regional lymph node metastasis cannot be assessed N1 Metastasis in 1 to 3 perirectal lymph nodes N2 Metastasis in 4 or more perirectal lymph nodes

Pathology report microscopic data Extramural deposits: TNM 7 Controversial! * For PROCARE, we continue to use TNM 5th edition - Extramural deposits that are not obviously within lymph nodes are regarded as discontinuous extensions of the main tumour if they measure<3mm - Extramural deposits are regarded as lymph node involvement if they measure > 3 mm in diameter. * Quirke et al, J Pathol 2010

Pathology report microscopic data pm : Distant metastasis: Mx distant metastasis cannot be assessed M0 no distant metastasis M1 distant metastasis confirmed at histologic examination ( cytological fluid + = M1cy+)

Pathology report microscopic data Resection margins: R0 Negative section margins R1 Microscopic tumour remains after resection R2 Macroscopic tumour remains after resection a positive CRM is defined as tumour extension or the presence of a positive lymph node < 1mm from the radial non peritonealised margin R1 = positive CRM or tumour located <1mm of CRM

Pathology report microscopic data Vascular invasion into extramural veins should be described. Presence of perineural and/or lymphatic invasion may be mentioned. The V and L substaging can be used to identify the presence of vascular or lymphatic invasion.

Pathology report microscopic data Histologic type according to the WHO classification : Adenocarcinoma» Mucinous carcinoma (colloid carcinoma)» Signet ring cell carcinoma Adenosquamous carcinoma or squamous carcinoma Small cell carcinoma Medullary carcinoma Undifferentiated carcinoma

Pathology report microscopic data Histologic grade: Four tiered system: Well differentiated (G1) Moderately differentiated (G2) Poorly differentiated -mucinous and signet ring cell carcinoma -(G3) Undifferentiated medullary carcinoma-(g4) Two tiered system: Low grade >50% of glandular structures( G1 + G2) High grade < 50% of glandular structures(g3 + G4)

ADDENDUM : Pathology report after neoadjuvant therapy The regression grade: Dworak Grade 0: no regression Grade 1: dominant tumour mass with obvious fibrosis and/or vasculopathy Grade 2: dominantly fibrotic changes with few tumour cells or groups (easy to find) Grade 3: very few (difficult to find microscopically) tumour cells in fibrotic tissue with or without mucous substance Grade 4: no tumour cells, only fibrotic mass (total regression or response) Grade 1 Grade 3 Dworak O.et al, Int J Colorectal Dis 1997 Grade 2 Grade 4

To confirm Dworak 4 Sufficient sampling is necessary 5 initials blocks from the site of tumour If still no tumour observed, whole area embedded If still no tumour, 3 levels from each block If still no tumour complete response : Dworak 4

After neoadjuvant therapy Mucus lake without tumour cells in a lymph node should be considered as ypn0

Check list

In summary Photographs of anterior and posterior mesorectal surface of unfixed, uninked and unopened specimen Photographs of overview of all transverse sections, detail of lesional section and CRM Sufficient sampling for histological investigation